NO942720D0 - 1,5-benzobiazepinderivater og medisinsk anvendelse av disse - Google Patents

1,5-benzobiazepinderivater og medisinsk anvendelse av disse

Info

Publication number
NO942720D0
NO942720D0 NO942720A NO942720A NO942720D0 NO 942720 D0 NO942720 D0 NO 942720D0 NO 942720 A NO942720 A NO 942720A NO 942720 A NO942720 A NO 942720A NO 942720 D0 NO942720 D0 NO 942720D0
Authority
NO
Norway
Prior art keywords
benzobiazepine
derivatives
medical use
medical
benzobiazepine derivatives
Prior art date
Application number
NO942720A
Other languages
English (en)
Other versions
NO305952B1 (no
NO942720L (no
Inventor
Harry Finch
David Gordon Trist
Giorgio Tarzia
Aldo Feriani
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of NO942720L publication Critical patent/NO942720L/no
Publication of NO942720D0 publication Critical patent/NO942720D0/no
Publication of NO305952B1 publication Critical patent/NO305952B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942720A 1992-01-21 1994-07-20 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater NO305952B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201180A GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds
PCT/EP1993/000098 WO1993014074A1 (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives and their use in medicine

Publications (3)

Publication Number Publication Date
NO942720L NO942720L (no) 1994-07-20
NO942720D0 true NO942720D0 (no) 1994-07-20
NO305952B1 NO305952B1 (no) 1999-08-23

Family

ID=10708914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942720A NO305952B1 (no) 1992-01-21 1994-07-20 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater

Country Status (29)

Country Link
US (2) US5580895A (no)
JP (1) JP3253723B2 (no)
KR (1) KR100263625B1 (no)
CN (1) CN1049217C (no)
AP (1) AP369A (no)
AU (2) AU3450193A (no)
BG (1) BG61876B1 (no)
CA (1) CA2087672C (no)
CZ (1) CZ283950B6 (no)
FI (1) FI111632B (no)
GB (1) GB9201180D0 (no)
GE (1) GEP20001968B (no)
HU (2) HU221297B1 (no)
IL (1) IL104447A (no)
IS (1) IS3970A (no)
MX (1) MX9300261A (no)
MY (1) MY131307A (no)
NO (1) NO305952B1 (no)
NZ (1) NZ245715A (no)
OA (1) OA09964A (no)
PH (1) PH30894A (no)
PL (1) PL175340B1 (no)
RO (1) RO114128B1 (no)
RU (1) RU2124009C1 (no)
SK (1) SK280173B6 (no)
TW (1) TW226013B (no)
UA (1) UA29416C2 (no)
WO (1) WO1993014074A1 (no)
ZA (1) ZA93375B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
AU688316B2 (en) * 1993-04-15 1998-03-12 Glaxo Wellcome Inc. 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
GB9308431D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9308421D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9314977D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB2280182A (en) * 1993-07-20 1995-01-25 Glaxo Spa Benzodiazepine derivatives
GB9315018D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
CZ286764B6 (en) * 1994-04-14 2000-06-14 Glaxo Wellcome Inc 5-Heterocyclo-1,5-benzodiazepine derivatives, process of their preparation and pharmaceutical preparation containing thereof
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
CA2239293A1 (en) 1995-12-11 1997-06-19 New England Medical Center Hosptials, Inc. Assay for and uses of peptide hormone receptor ligands
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
US6239131B1 (en) * 1996-12-10 2001-05-29 Zeria Pharmaceutical Co., Ltd. 1,5 Benzodiazepine derivatives
EP1615878B1 (en) 2003-01-14 2012-04-04 Cytokinetics, Inc. Compounds, compositions and methods of treatment for heart failure
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
KR20060125805A (ko) * 2003-11-18 2006-12-06 베링거 인겔하임 인터내셔날 게엠베하 고체 약제학적 제제 형태
JP5080970B2 (ja) 2004-06-17 2012-11-21 サイトキネティクス・インコーポレーテッド 心疾患を治療するための置換尿素誘導体
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
EP1959960B1 (en) 2005-12-15 2013-04-10 Cytokinetics, Inc. Certain chemical entities, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
US7718657B2 (en) 2005-12-16 2010-05-18 Cytokinetics, Inc. Certain indanyl urea modulators of the cardiac sarcomere
JP5178526B2 (ja) 2005-12-19 2013-04-10 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
ES2613808T3 (es) 2011-07-29 2017-05-26 Oncotherapy Science, Inc. Péptido derivado de ERAP1 y uso del mismo
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
AU2016297024B2 (en) 2015-07-22 2021-03-04 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as RSV inhibitors
EP3402799B1 (en) 2016-01-15 2022-05-04 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
EP3582784B1 (en) 2017-02-16 2022-06-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) * 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
MX2020004084A (es) 2017-09-29 2020-07-29 Enanta Pharm Inc Agentes farmaceuticos como inhibidores del rsv para utilizar en combinacion.
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
US10975094B2 (en) 2018-04-11 2021-04-13 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US20220098256A1 (en) 2018-11-30 2022-03-31 Tokushima University Therapeutic agent for breast cancer comprising big3-phb2 interaction-inhibiting peptide derived from phb2
WO2020190935A1 (en) 2019-03-18 2020-09-24 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as rsv inhibitors
WO2020210246A1 (en) 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
WO2022086840A1 (en) 2020-10-19 2022-04-28 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ZA93375B (en) 1994-07-18
NZ245715A (en) 1995-07-26
TW226013B (no) 1994-07-01
GB9201180D0 (en) 1992-03-11
CN1049217C (zh) 2000-02-09
AP369A (en) 1994-11-06
IL104447A0 (en) 1993-05-13
WO1993014074A1 (en) 1993-07-22
NO305952B1 (no) 1999-08-23
JPH07118244A (ja) 1995-05-09
CZ173694A3 (en) 1995-09-13
NO942720L (no) 1994-07-20
AU661749B2 (en) 1995-08-03
US5637697A (en) 1997-06-10
IL104447A (en) 1998-02-22
AP9300478A0 (en) 1993-01-31
BG98881A (bg) 1995-03-31
CA2087672A1 (en) 1993-07-22
SK280173B6 (sk) 1999-09-10
AU3193593A (en) 1993-07-22
SK86494A3 (en) 1995-03-08
FI943421A (fi) 1994-07-19
CN1074678A (zh) 1993-07-28
AU3450193A (en) 1993-08-03
UA29416C2 (uk) 2000-11-15
BG61876B1 (bg) 1998-08-31
RU94037768A (ru) 1996-08-10
KR100263625B1 (ko) 2000-11-01
JP3253723B2 (ja) 2002-02-04
FI943421A0 (fi) 1994-07-19
HUT67375A (en) 1995-03-28
US5580895A (en) 1996-12-03
HU221297B1 (en) 2002-09-28
IS3970A (is) 1993-07-22
RU2124009C1 (ru) 1998-12-27
CA2087672C (en) 2003-08-05
MY131307A (en) 2007-08-30
FI111632B (fi) 2003-08-29
RO114128B1 (ro) 1999-01-29
PL175340B1 (pl) 1998-12-31
MX9300261A (es) 1994-03-31
GEP20001968B (en) 2000-03-05
HU211295A9 (en) 1995-11-28
HU9402150D0 (en) 1994-09-28
PH30894A (en) 1997-12-23
OA09964A (en) 1995-12-11
CZ283950B6 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
NO942720D0 (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DE69415163D1 (de) ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL
IS4481A (is) Díhýdrópyramídín og notkun þeirra
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
NO307254B1 (no) 1,2,4-oksadiazolderivater og parasittbekjempningsmiddel inneholdende samme
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
DK0821692T3 (da) Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf
DK0687728T3 (da) Reovirus stamme 2177 og vaccine indeholdende samme
IS1813B (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO303392B1 (no) Polyetere, samt fremstilling og anvendelse av disse
ZA913171B (en) 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
ZA92357B (en) Amide derivatives and their therapeutic use.
DE69226430D1 (de) Fungizide 4-thioxooxazolidin-2-one und 4-iminooxazolidin-2-one
NO905221D0 (no) Steriliseringsblandinger og anvendelse derav.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO985572L (no) Substituerte amidinobenzenderivater og medisinske preparater derav
DK36390D0 (da) Forbindelser og anvendelse